ABVC BioPharma Inc (ABVC)
1.59
+0.11
(+7.43%)
USD |
NASDAQ |
Apr 25, 16:00
1.56
-0.03
(-1.89%)
After-Hours: 07:21
ABVC BioPharma Price to Book Value: 2.002 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 2.002 |
| April 24, 2024 | 1.863 |
| April 23, 2024 | 1.700 |
| April 22, 2024 | 1.309 |
| April 19, 2024 | 1.246 |
| April 18, 2024 | 1.322 |
| April 17, 2024 | 1.284 |
| April 16, 2024 | 1.410 |
| April 15, 2024 | 1.372 |
| April 12, 2024 | 1.372 |
| April 11, 2024 | 1.448 |
| April 10, 2024 | 1.435 |
| April 09, 2024 | 1.486 |
| April 08, 2024 | 1.574 |
| April 05, 2024 | 1.599 |
| April 04, 2024 | 1.612 |
| April 03, 2024 | 1.624 |
| April 02, 2024 | 1.624 |
| April 01, 2024 | 1.725 |
| March 28, 2024 | 1.649 |
| March 27, 2024 | 1.511 |
| March 26, 2024 | 1.612 |
| March 25, 2024 | 1.322 |
| March 22, 2024 | 1.347 |
| March 21, 2024 | 1.334 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.348 |
| March 19, 2024 | 1.410 |
| March 18, 2024 | 1.460 |
| March 15, 2024 | 1.473 |
| March 14, 2024 | 1.511 |
| March 13, 2024 | 1.548 |
| March 12, 2024 | 1.586 |
| March 11, 2024 | 1.536 |
| March 08, 2024 | 1.574 |
| March 07, 2024 | 1.275 |
| March 06, 2024 | 1.265 |
| March 05, 2024 | 1.234 |
| March 04, 2024 | 1.265 |
| March 01, 2024 | 1.203 |
| February 29, 2024 | 1.234 |
| February 28, 2024 | 1.239 |
| February 27, 2024 | 1.254 |
| February 26, 2024 | 1.265 |
| February 23, 2024 | 1.224 |
| February 22, 2024 | 1.234 |
| February 21, 2024 | 1.214 |
| February 20, 2024 | 1.224 |
| February 16, 2024 | 1.295 |
| February 15, 2024 | 1.305 |
| February 14, 2024 | 1.285 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4293
Minimum
Oct 06 2023
263.24
Maximum
Sep 30 2019
29.03
Average
8.885
Median
Price to Book Value Benchmarks
| NeuBase Therapeutics Inc | 0.1804 |
| Sutro Biopharma Inc | 1.758 |
| Reviva Pharmaceuticals Holdings Inc | 14.55 |
| Flora Growth Corp | 2.569 |
| Journey Medical Corp | 3.428 |
Price to Book Value Related Metrics
| PS Ratio | 48.47 |
| Price | 1.59 |
| Earnings Yield | -156.8% |
| Market Cap | 16.79M |